GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive: GATA2 also plays a role in other hematopoietic malignancies with the acquisition of neomorphic mutations in the second zinc finger of GATA2 resulting in poorer outcomes in patients with chronic myeloid leukemia (Zhang et al., 2008).